How to treat hypertension in blacks: review of the evidence

Acta Clinica Belgica
L D KolaJ M Krzesinski

Abstract

Presentation, response to therapy, and clinical outcome differ according to race for patients with hypertension. Black patients have a higher prevalence and earlier onset of hypertension than other ethnic groups, with poorer prognosis than white patients. Blacks are more likely to be salt-sensitive, and to have a low plasma renin activity than are whites. They are at much greater risk of developing cardiovascular and renal complications. Despite many advances in the understanding and treatment of cardiovascular diseases, black patients continue to have increased morbidity and mortality from the end-organ complications of hypertension. The explanations for these observations remain incompletely understood, but genetic differences, added to socio-economic and environmental factors, have been proposed to explain this disparity. The first therapeutic approach is to decrease salt and increase potassium intakes. Diuretics (thiazides and potassium-sparing agents) and calcium channel blockers constitute the first antihypertensive drug choices. The angiotensin-converting-enzyme inhibitors, the angiotensin II receptor blockers and beta-blockers appear to be less effective in blacks with regard to uncomplicated hypertension, especially in...Continue Reading

References

Jan 12, 1979·JAMA : the Journal of the American Medical Association·J H LaraghT G Pickering
Mar 12, 1992·The New England Journal of Medicine·J P BroderickR Miller
Dec 1, 1991·Hypertension·G A HarshfieldF B Stapelton
Feb 6, 1991·JAMA : the Journal of the American Medical Association·M J KlagL H Kuller
Mar 1, 1991·Stroke; a Journal of Cerebral Circulation·A L KlatskyG D Friedman
Apr 1, 1991·Circulation·L R Caplan
Apr 1, 1991·Circulation·C L Curry
Oct 26, 1989·The New England Journal of Medicine·J H PrattN S Fineberg
Mar 1, 1969·Circulation·B N ChiangF H Epstein
Feb 1, 1994·Hypertension·N D FisherN K Hollenberg
Mar 1, 1996·Hypertension·M H Weinberger
Jul 1, 1996·Clinical Pharmacology and Therapeutics·N J BrownM R Griffin
Feb 1, 1997·American Journal of Public Health·R CooperR Wilks
May 1, 1997·Journal of Hypertension·G BakrisH Gavras
Aug 26, 1998·The New England Journal of Medicine·S S GottliebR A Vogel
Nov 20, 1998·Hypertension·R S Cooper, J S Kaufman
Jun 21, 2001·JAMA : the Journal of the American Medical Association·L Y AgodoaUNKNOWN African American Study of Kidney Disease and Hypertension (AASK) Study Group
Sep 5, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·K C NorrisH J Ward
May 25, 2002·Public Health Nutrition·H H Vorster
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
Mar 8, 2003·Archives of Internal Medicine·Janice G DouglasUNKNOWN Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks
Apr 8, 2003·Journal of the American College of Cardiology·John M FlackElijah Saunders
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
May 24, 2003·Journal of Human Hypertension·O AkinboboyeO Akinkugbe
Nov 25, 2003·Kidney International·Robert B Toto
Jan 14, 2004·Kidney International·Abraham AvivAlan B Weder
Jan 20, 2004·Advances in Renal Replacement Therapy·Suying LiAllan J Collins

❮ Previous
Next ❯

Citations

May 1, 2012·Survey of Ophthalmology·Sobha SivaprasadJennifer Evans
Oct 26, 2011·Journal of Clinical Pharmacy and Therapeutics·M C S WongS M Griffiths
May 12, 2011·Tropical Medicine & International Health : TM & IH·Kehinde O Kolapo, Sandro Vento
Oct 4, 2017·Journal of Applied Physiology·Ida T FonkoueJason R Carter

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

La Presse médicale
Jean-Pierre Fauvel, Maurice Laville
Nederlands tijdschrift voor geneeskunde
G J TimmersR O Gans
Nihon rinsho. Japanese journal of clinical medicine
Hiroo KumagaiKojiro Yamamoto
Medizinische Monatsschrift für Pharmazeuten
Andreas Schuchert
© 2021 Meta ULC. All rights reserved